TrialJAMA2013

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Margaret M Redfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.